Neuroendocrinal regulation of bone metabolism in osteoarthritis of large joints (review)

Cover Page


Cite item

Full Text

Abstract

The regulation of bone metabolism by adrenergic, cholinergic and endocrine transmitters in osteoarthritis is reviewed. Regulatory effects of α- and β-receptor mechanisms of norepinephrine, M- and N-receptors of acetylcholine, glucocorticosteroids, PTH and peptidergic systems in the bone remodeling process are characterized that can serve as a basis for the development of promising therapies osteoarthritis.

About the authors

A. E. Lychkova

Moscow Clinical Research Center of Moscow Health Department

Author for correspondence.
Email: noemail@neicon.ru
Russian Federation

L. Y. Shirokova

Yaroslavl State Medical University

Email: noemail@neicon.ru
Russian Federation

E. V. Kryukova

Yaroslavl State Medical University; Vologda Regional Clinic Hospital

Email: noemail@neicon.ru
Russian Federation

References

  1. Алексеева Л.И., Зайцева Е.М. Субхондральная кость при остеоартрозе: новые возможности терапии. Российский медицинский журнал. 2004; 12(20):1133-1136.
  2. Джексон Э. Средства, действующие на выделительную и сердечно-сосудистую систему. В кн.: Клиническая фармакология. А.Г. Гилман (ред.). М.: Практика; 2006. 1648 с.
  3. Кашеварова Н.Г., Алексеева Л.И. Факторы риска прогрессирования остеоартроза коленных суставов. Научно-практическая ревматология. 2014; 52(5):553-561.
  4. Носков С.М., Широкова Л.Ю., Жомова М.В. Глюкокортикостероиды в лечении остеоартрита тазобедренных и коленных суставов. Клиническая геронтология. 2010; (16):49-53.
  5. Цветкова Е.С., Иониченок Н.Г., Карусинов П.С. Лечение ревматических болезней. Клинико-инструментальная оценка влияния фармакотерапии на течение остеоартроза коленных суставов. Научно-практическая ревматология. 2010; (1):69-74.
  6. Широкова Л.Ю., Жомова М.В., Лаврухин В.В. Практика локальной глюкокортикоидной терапии при остеоартрозе - дополнение к рекомендациям. Проблемы стандартизации в здравоохранении. 2009; (2):26-29.
  7. Широкова Л., Носков С., Широкова К., Дыбин С., Политов Я., Мокроусова М., Андрейченко Е. Показатели оксидативного стресса в динамике лечения остеоартроза симптоммодифицирующими препаратами быстрого и медленного действия. Врач. 2014; (3):30-34.
  8. Aitken S.J., Landao-Bassonga E., Ralston S.H., Idris A.I. Beta2-adrenoreceptor ligands regulate osteoclast differentiation in vitro by direct and indirect mechanisms. Arch Biochem Biophys. 2009; 482:96-103.
  9. Baldock P.A., Sainsbury A., Couzens M., Enriquez R.F., Thomas G.P., Gardiner E.M., Herzog H. Hypothalamic Y2 receptors regulate bone formation. J Clin Invest. 2002; 109(7):915-921.
  10. Blackwood H.J. Adaptive changes in the mandibular joints with function. Dent Clin North Am. 1966:559-566.
  11. Bliziotes M., Eshleman A., Burt-Pichat B., Zhang X.W., Hashimoto J., Wiren K., Chenu C. Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells. Bone. 2006; 39(6):1313-1321.
  12. Bonnet N., Benhamou C.L., Beaupied H., Laroche N., Vico L., Dolleans E., Courteix D. Doping dose of salbutamol and exercise: deleterious effect on cancellous and cortical bones in adult rats. J Appl Physiol. 2007; 102:1502-1509.
  13. Brandt K.D., Doherty M., Lohmander L.S. (eds). Osteoarthritis. Oxford: Oxford University Press; 1998.
  14. Bukoski R.D., Bian K., Wang Y., Mupanomunda M. Perivascular sensory nerve Ca2+ receptor and Ca2+-induced relaxation of isolated arteries. Hypertension. 1997; 30(6):1431-1439.
  15. Buma P., Verschuren C., Versleyen D., Van der Kraan P., Oestreicher A.B. Calcitonin gene-related peptide, substance P and GAP-43/B-50 immunoreactivity in the normal and arthrotic knee joint of the mouse. Histochem. 1992; 98:327-339.
  16. Caulfield M.P. Muscarinic receptors - characterization, coupling and function. Pharmacol Ther. 1993; 58:319-379.
  17. Caulfield M.P., Birdsall N.J.M. International union of pharmacology. Xvii. Classification of muscarinic acetylcholine receptors. Pharmacol Rev. 1998; 50:279-290.
  18. Dani J.A., Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol. 2007; 47:699-729.
  19. Ducy P., Amling M., Takeda S., Priemel M., Schilling A.F., Beil F.T., Shen J., Vinson C., Rueger J.M., Karsenty G. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 2000; 100(2):197-207.
  20. Duncan C.P., Shim S.S. J. Edouard Samson Address: the autonomic nerve supply of bone. An experimental study of the intraosseous adrenergic nervi vasorum in the rabbit. J Bone Joint Surg Br. 1977; 59:323-330.
  21. Eitner A., Pester J., Nietzsche S., Hofmann G.O., Schaible H.G. The innervation of synovium of human osteoarthritic joints in comparison with normal rat and sheep synovium. Osteoarthritis Cartilage. 2013; 21(9):1383-1391.
  22. Elefteriou F. Regulation of bone remodeling by the central and peripheral nervous system. Arch Biochem Biophys. 2008; 473(2):231-236.
  23. Elefteriou F., Campbell P., Ma Y. Control of bone remodeling by the peripheral sympathetic nervous system. Calcif Tissue Int. 2014; 94(1):140-151.
  24. Fonseca T.L., Jorgetti V., Costa C.C., Capelo L.P., Covarrubias A.E., Moulatlet A.C., Teixeira M.B., Hesse E., Morethson P., Beber E.H., Freitas F.R., Wang C.C., Nonaka K.O., Oliveira R., Casarini D.E., Zorn T.M., Brum P.C., Gouveia C.H. Double disruption of alpha2A- and alpha2C-adrenoceptors results in sympathetic hyperactivity and high-bone-mass phenotype. J Bone Miner Res. 2011; 26:591-603.
  25. Han J., Zou Z., Zhu C., Deng J., Wang J., Ran X., Shi C., Ai G., Li R., Cheng T., Su Y. DNA synthesis of rat bone marrow mesenchymal stem cells through alpha1-adrenergic receptors. Arch Biochem Biophys. 2009; 490:96-102.
  26. Helfrich M.H., Evans D.E., Grabowski P.S., Pollock J.S., Ohshima H., Ralston S.H. Expression of nitric oxide synthase isoforms in bone and bone cell cultures. J Bone Miner Res. 1997; 12(7):1108-1115.
  27. Hilal G., Martel-Pelletier J., Pelletier J.P., Dual N., Lajeunesse D. Abnormal regulation of urokinase plasminogen activator by insulin-like growth factor-w in human osteoarthritic subchondral osteoblasts. Arthritis Rheum. 2009; 42:2112-2122.
  28. Huang H.H., Brennan T.C., Muir M.M., Mason R.S. Functional alpha1- and beta2-adrenergic receptors in human osteoblasts. J Cell Physiol. 2009; 220:267-275.
  29. Hutton C.W., Higgs E.R., Jackson P.C., Watt I., Dieppe P.A. 99mTc HMDP bone scanning in generalised nodal osteoarthritis. II. The four hour bone scan image predicts radiographic change. Ann Rheum Dis. 1986; 45(8):622-626.
  30. Johnson R.H., Spaulding J.M. Disorders of the autonomic nervous system. Chapter 3. The nervous control of the circulation and its investigation. Contemp Neurol Ser. 1974; 33-58.
  31. Kondo A., Mogi M., Koshihara Y., Togari A. Signal transduction system for interleukin-6 and interleukin-11 synthesis stimulated by epinephrine in human osteoblasts and human osteogenic sarcoma cells. Biochem Pharmacol. 2001; 61:319-326.
  32. Kondo H., Takeuchi S., Togari A. β-Adrenergic signaling stimulates osteoclastogenesis via reactive oxygen species. Am J Physiol Endocrinol Metab. 2013; 304(5):E507-E515.
  33. Locker M., Bitard J., Collet C., Poliard A., Mutel V., Launay J.M., Kellermann O. Stepwise control of osteogenic differentiation by 5-HT(2B) receptor signaling: nitric oxide production and phospholipase A2 activation. Cell Signal. 2006; 18(5):628-639.
  34. Lotz M., Martel-Pelletier J., Christiansen C., Brandi M.L., Bruyère O., Chapurlat R., Collette J., Cooper C., Giacovelli G., Kanis J.A., Karsdal M.A., Kraus V., Lems W.F., Meulenbelt I., Pelletier J.P., Raynauld J.P., Reiter-Niesert S., Rizzoli R., Sandell L.J., Van Spil W.E., Reginster J.Y. Value of biomarkers in osteoarthritis: current status and perspectives. Ann Rheum Dis. 2013; 72(11):1756-1763.
  35. Macfarlane D.G., Buckland Wright J.C., Emery P., Fogelman I., Clark B., Lynch J. Comparison of clinical, radionuclide, and radiographic features of osteoarthritis of the hands. Ann Rheum Dis. 1991; 50:623-626.
  36. Mach D.B., Rogers S.D., Sabino M.C., Luger N.M., Schwei M.J., Pomonis J.D., Keyser C.P., Clohisy D.R., Adams D.J., O’Leary P., Mantyh P.W. Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience. 2002; 113(1):155-166.
  37. McCarron D.A. Calcium metabolism and hypertension. Kidney Int. 1989; 35:717-736.
  38. Mitchell J., Lai L.P., Peralta F., Xu Y., Sugamori K. Beta2-adrenergic receptors inhibit the expression of collagen type II in growth plate chondrocytes by stimulating the AP-1 factor Jun-B. Am J Physiol Endocrinol Metab. 2011; 300:E633-E639.
  39. Nakashima T., Hayashi M., Fukunaga T., Kurata K., Oh-Hora M., Feng J.Q., Bonewald L.F., Kodama T., Wutz A., Wagner E.F., Penninger J.M., Takayanagi H. Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 2011; 17:1231-1234.
  40. Ohtori S., Inoue G., Koshi T., Ito T., Watanabe T., Yamashita M., Yamauchi K., Suzuki M., Doya H., Moriya H., Takahashi Y., Takahashi K. Sensory innervation of lumbar vertebral bodies in rats. Spine. 2007; 32(14):1498-1502.
  41. Patel M.S., Elefteriou F. The new field of neuroskeletal biology. Calcif Tissue Int. 2007; 80(5):337-347.
  42. Radin E.L., Abernethy P.J., Townsend P.M., Rose R.M. The role of bone changes in the degeneration of articular cartilage in osteoarthrosis. Acta Orthop Belg. 1978; 44(1):55-63.
  43. Reid I.R. Effects of beta-blockers on fracture risk. J Musculoskelet Neuron Interact. 2008; 8:105-110.
  44. Rothem D.E., Rothem L., Soudry M., Dahan A., Eliakim R. Nicotine modulates bone metabolism-associated gene expression in osteoblast cells. J Bone Miner Metab. 2009; 27:555-561.
  45. Sainsbury A., Baldock P.A., Schwarzer C., Ueno N., Enriquez R.F., Couzens M., Inui A., Herzog H., Gardiner E.M. Synergistic effects of Y2 and Y4 receptors on adiposity and bone mass revealed in double knockout mice. Mol Cell Biol. 2003; 23(15): 1225-1233.
  46. Salo P.T., Seeratten R.A., Erwin W.M., Bray R.C. Evidence for a neuropathic contribution to the development of spontaneous knee osteoarthrosis in a mouse model. Acta Orthop Scand. 2002; 73:77-84.
  47. Shi Y., Oury F., Yadav V.K., Wess J., Liu X.S., Guo X.E., Murshed M., Karsenty G. Signaling through the M(3) muscarinic receptor favors bone mass accrual by decreasing sympathetic activity. Cell Metab. 2010; 11:231-238.
  48. Strange-Vognsen H.H., Laursen H. Nerves in human epiphyseal uncalcified cartilage. J Pediatr Orthop B. 1997; 6:56-58.
  49. Suri S., Gill S.E., Massena de Camin S., Wilson D., McWilliams D.F., Walsh D.A. Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis. Ann Rheum Dis. 2007; 66(11):1423-1428.
  50. Takeda S., Elefteriou F., Levasseur R., Liu X., Zhao L., Parker K.L., Armstrong D., Ducy P., Karsenty G. Leptin regulates bone formation via the sympathetic nervous system. Cell. 2002; 11(3):305-317.
  51. van’t Hof R.J., Macphee J., Libouban H., Helfrich M.H., Ralston S.H. Regulation of bone mass and bone turnover by neuronal nitric oxide synthase. Endocrinology. 2004; 145(11):5068-5074.
  52. Walker L.M., Preston M.R., Magnay J.L., Thomas P.B., El Haj A.J. Nicotinic regulation of c-fos and osteopontin expression in human-derived osteoblast-like cells and human trabecular bone organ culture. Bone. 2001; 28:603-608.
  53. Xiong J., Onal M., Jilka R.L., Weinstein R.S., Manolagas S.C., O’Brien C.A. Matrix-embedded cells control osteoclast formation. Nat Med. 2011; 17:1235-1241.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 82474 от 10.12.2021.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies